Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $550 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $550.
July 17, 2023 | 1:53 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eli Lilly's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $550.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Eli Lilly. The maintained price target of $550 suggests that the analyst believes the stock has potential for significant growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100